| P50 | author | Anna Rull | Q41530405 |
| | Jorge Joven | Q41878569 |
| P2093 | author name string | Judit Marsillach | |
| | Jordi Camps | |
| | Natàlia Ferré | |
| | Bharti Mackness | |
| | Michael Mackness | |
| | Raul Beltran | |
| P2860 | cites work | Ethanol consumption reduces the proteolytic capacity and protease activities of hepatic lysosomes | Q70836907 |
| | Monocyte chemoattractant protein 1 (MCP-1) expression occurs in toxic rat liver injury and human liver disease | Q72712334 |
| | Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells | Q73389643 |
| | Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism | Q73965887 |
| | Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R | Q77380948 |
| | Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants | Q77416567 |
| | Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis | Q77475942 |
| | Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease | Q79867587 |
| | Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model | Q80127451 |
| | The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity | Q80160399 |
| | Chromogenic and fluorogenic assays for the lactonase activity of serum paraoxonases | Q81576379 |
| | Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases | Q82697315 |
| | Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue | Q25257314 |
| | Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis | Q28572042 |
| | AP-1 function and regulation | Q29618422 |
| | Reactive oxygen species, cell signaling, and cell injury | Q33991757 |
| | 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications | Q34169039 |
| | HDL and the inflammatory response induced by LDL-derived oxidized phospholipids | Q34220276 |
| | Oxidative stress-related molecules and liver fibrosis | Q34387346 |
| | Chemokines in the pathogenesis of liver disease: so many players with poorly defined roles | Q35041594 |
| | Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies | Q35173613 |
| | Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ | Q35649446 |
| | Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. | Q35763752 |
| | Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease. | Q35900706 |
| | Peroxisome proliferator-activated receptor-delta, a regulator of oxidative capacity, fuel switching and cholesterol transport | Q36660434 |
| | Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? | Q36830400 |
| | Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells | Q40555766 |
| | 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells | Q42454202 |
| | The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene | Q42517848 |
| | Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis | Q42552980 |
| | Purification and characterization of paraoxon hydrolase from rat liver | Q42985351 |
| | Hepatic paraoxonase activity alterations and free radical production in rats with experimental cirrhosis. | Q43736578 |
| | Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. | Q43862808 |
| | Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver | Q44457672 |
| | Comprehensive analysis of differential gene expression profiles on carbon tetrachloride-induced rat liver injury and regeneration | Q46553079 |
| | Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues | Q46623909 |
| | Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma | Q46742699 |
| | Transgene expression of human PON1 Q in mice protected the liver against CCl4-induced injury | Q46877614 |
| | Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells | Q57244183 |
| | Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice | Q60321190 |
| | Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells | Q60571681 |
| | Inhibition of hepatic cell nuclear DNA fragmentation by zinc in carbon tetrachloride-treated rats | Q60664727 |
| | The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease | Q61945529 |
| P304 | page(s) | 3 | |
| P577 | publication date | 2009-01-14 | |
| P1433 | published in | BMC Gastroenterology | Q15759922 |
| P1476 | title | Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease | |
| P478 | volume | 9 | |